期刊
JOURNAL OF DRUG TARGETING
卷 30, 期 8, 页码 801-818出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/1061186X.2022.2069782
关键词
Pharmacokinetic modulation; multidrug resistance; P-glycoprotein inhibitors; reversal of resistance; enhanced cancer management
资金
- Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFPRP-38-166-1442]
- King Abdulaziz University, DSR, Jeddah, Saudi Arabia
Chemotherapy is a crucial treatment for cancer, but its clinical application is limited to patients with multidrug resistance. Co-administration of natural P-gp inhibitors with chemotherapeutics has the potential to enhance the efficacy of chemotherapy against MDR cancer. The use of nanotechnology for co-delivery of therapeutic components could improve the anticancer potential of chemotherapeutic agents.
Chemotherapy is the mainstay in cancer treatment; however, its application is clinically limited to patients with multidrug resistance (MDR). MDR reverses the role of chemotherapy through significant attribution to pharmacokinetic characteristics, where ATP-binding cassette transporter proteins, P-glycoprotein (P-gp), pump out the intracellularly transported chemotherapeutics from the cancer cells. Therefore, overexpression of such receptors on MDR cancer cell surfaces tends to decrease the efficacy of a large number of existing chemotherapeutics. P-gp inhibitors, especially of natural origin, play a vital role in enhancing the cellular concentration of clinically applicable chemotherapeutics. Therefore, co-administration of these natural P-gp inhibitors with chemotherapeutics could improve chemotherapeutic efficacy against MDR cancer, which has been evidenced in the literature. Co-delivery of these therapeutic components can effectively be made using the emerging nanotechnology platform, which could facilitate controlled delivery of the incorporated components to the cancerous microenvironment, through passive and active targeting. Thereby, cellular retention of chemotherapeutic agents by the P-gp mediated inhibitory effect on the efflux pump using the nanocarrier co-delivery platform could improve the anticancer potential of the chemotherapeutics. This review has presented the advancement of naturally occurring P-gp inhibitors as a promising adjuvant in chemotherapy to modulate the pharmacokinetic properties of chemotherapeutic agents using the nanotechnology platform.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据